ライフサイエンスコーパス: oropharynx

1 P HNSCCs were found in sites adjacent to the oropharynx.

2 ly cleared virus from blood but not from the oropharynx.

3 d to collect secretions from the trachea and oropharynx.

4 erior nasopharynx or orally to the posterior oropharynx.

5 ransmission of strains between the blood and oropharynx.

6 rostral oropharynx, velopharynx, and caudal oropharynx.

7 Similar effects occurred in the caudal oropharynx.

8 uman serum albumin (HSA) administered to the oropharynx.

9 patients with cancers of the oral tongue and oropharynx.

10 malignancies of the vulva, vagina, anus, and oropharynx.

11 oropharynx, and retrieving the ends from the oropharynx.

12 ns and/or less microbial colonization of the oropharynx.

13 notable for minor swelling of the posterior oropharynx.

14 ated with patient outcome for cancers of the oropharynx.

15 showed an extension into the nasal cavity or oropharynx.

16 who presented with discharging sinus in the oropharynx.

17 ere HPV infection is less common than in the oropharynx.

18 seudomonas aeruginosa was instilled into the oropharynx.

19 the cervix, vulva, vagina, anus, penis, and oropharynx.

20 imens or collection devices pass through the oropharynx.

21 rus whose primary site of replication is the oropharynx.

22 ated with patient outcome for cancers of the oropharynx.

23 d and in episodic shedding of virus from the oropharynx.

24 ly impaired in ability to colonize the mouse oropharynx.

25 aired in their ability to colonize the mouse oropharynx.

26 irus to persist in, and to be shed from, the oropharynx.

27 genes and whether MalR helps GAS infect the oropharynx.

28 contributes to the persistence of GAS in the oropharynx.

29 jor breakdown product of starch in the human oropharynx.

30 the lingual and palatine tonsils within the oropharynx.

31 erapy (63-76.8 Gy) for primary tumors of the oropharynx.

32 he ability of GAS to successfully infect the oropharynx.

33 Oropharynx (40%) and oral cavity (27%) were the predomin

34 .8%, and blue food coloring was found in the oropharynx 5.1% of the time.

35 ived from an upwards growth of the primitive oropharynx, a K5-expressing tissue.

36 In the rostral oropharynx, airway area increased with individual and co

37 amples, but these viruses are present in the oropharynx and are shed in saliva.

38 ted birds shed virus at high titers from the oropharynx and cloaca, and infection was fatal.

39 genic bacteria or commensal organisms of the oropharynx and genital tract, (iii) a 95% probability of

40 A streptococcus (GAS) commonly colonizes the oropharynx and nonintact skin.

41 to diverse communities of microbes from the oropharynx and other sources, and over the past decade,

42 a gram-negative anaerobe that resides in the oropharynx and possesses numerous virulence factors that

43 (aerobic Gram-bacilli except E. coli) in the oropharynx and rectum.

44 data suggest that KSHV can replicate in the oropharynx and that salivary contact could contribute to

45 he endodermal epithelial cells that line the oropharynx and the adjacent mesenchyme that is derived f

46 tain outside a virtual cavity connecting the oropharynx and the back of the mouth, which prevents foo

47 f polymyxin/tobramycin/amphotericin B in the oropharynx and the gastric tube plus a mupirocin/chlorhe

48 omas (HNCs), especially those arising in the oropharynx and the tonsils.

49 is a small secreted protein expressed in the oropharynx and upper airways of humans, mice, rats, and

50 is usually caused by organisms living in the oropharynx and upper airways.

51 than anteroposterior dimension in the caudal oropharynx and velopharynx, especially as airway cross-s

52 at the higher pressure ranges in the caudal oropharynx and velopharynx.

53 responses of two squamous carcinomas, SCC-9 (oropharynx) and HEP-2 (larynx), were examined to determi

54 57 years, 92% had stage 4 disease, 71% were oropharynx, and 100% had a performance status of 0.

55 man cancers, such as those in the esophagus, oropharynx, and colon.

56 Motion of the nasopharynx, oropharynx, and hypopharynx was characterized as static

57 The nasopharynx, oropharynx, and hypopharynx were characterized in terms

58 yed for S. aureus colonization of the nares, oropharynx, and inguinal region and risk factors for S.

59 t of head and neck cancers, primarily in the oropharynx, and is largely responsible for the rising wo

60 the most to least prevalent are the larynx, oropharynx, and nasopharynx.

61 ied epithelium of the skin, lung, esophagus, oropharynx, and other tissues.

62 n microorganisms normally found in the human oropharynx, and Pal-resistant pneumococci could not be d

63 the catheter through the nostrils, into the oropharynx, and retrieving the ends from the oropharynx.

64 sh volume, presence of blue food coloring in oropharynx, and stool frequency were recorded every 4 hr

65 the first site of CWD prion entry is in the oropharynx, and the initial phase of prion amplification

66 e measured in the rostral oropharynx, caudal oropharynx, and velopharynx with and without bilateral s

67 To evaluate the posterior oropharynx as a source of HIV shedding, we studied 64 HI

68 e II transport cycles (food transport to the oropharynx before swallowing).

69 and carcinomas in the anogenital region and oropharynx between 1990 and 2015 were extracted.

70 vation reduced GAS colonization of the mouse oropharynx but did not detrimentally affect invasive inf

71 ast, unopposed tongue protrusion dilates the oropharynx, but has a minimal effect on pharyngeal airwa

72 reptococcus (GAS) commonly infects the human oropharynx, but the initial molecular events governing t

73 ection, aphthous ulceration of the mouth and oropharynx can become extensive and debilitating.

74 Human papillomavirus-associated oropharynx cancer (HPVA-OPC) is rapidly increasing in in

75 ts with human papillomavirus (HPV) -positive oropharynx cancer (OPC) relative to HPV-negative OPC, bu

76 study human papillomavirus (HPV)-associated oropharynx cancer separately or, at least, stratify by H

77 cross all head and neck cancer sites: HR for oropharynx cancer, 0.26; 95% CI, 0.18-0.39; for oral cav

78 Before the 1990s, hypopharynx and oropharynx cancers carried the highest excess risk of SP

79 eck cancers (patients; 180 oral cancers, 135 oropharynx cancers, and 247 hypopharynx/larynx cancers)

80 teral diameters were measured in the rostral oropharynx, caudal oropharynx, and velopharynx with and

81 inhalation, the anatomical structure of the oropharynx creates an air curtain outside a virtual cavi

82 Persistence of C. pneumoniae in the oropharynx creates challenges for outbreak control measu

83 y human epithelial cells from the epidermis, oropharynx, esophagus and cervix into genetically define

84 for adaptations of the geometry of the human oropharynx for efficient transport of food volatiles tow

85 he bacterial pathogens and commensals of the oropharynx, genital tract, and rectum.

86 were enrolled and specimens from the nares, oropharynx, groin, perianal area, and wounds were prospe

87 drates are not readily available in the naso-oropharynx; however, N- and O-linked glycans are common

88 re similarly associated with survival in the oropharynx (HR for serology, 0.16; 95% CI, 0.03-0.47; fo

89 squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx treated with definit

90 squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx undergoing first-line

91 Patients with LASCCHN of the oropharynx, hypopharynx, or larynx with measurable disea

92 nts with known carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx.

93 ent for aphthous ulceration of the mouth and oropharynx in patients with HIV infection.

94 DeltamalR strain persistently colonized the oropharynx in significantly fewer mice than the parental

95 The human oropharynx is a reservoir for many potential pathogens,

96 ed in HPV-positive cancers of the cervix and oropharynx is miR-424.

97 te smoking, causes most cancers of the lung, oropharynx, larynx, and esophagus in the USA, and approx

98 herapy for the following sites: oral tongue, oropharynx, larynx, and hypopharynx.

99 attributable mortality (cancers of the lung, oropharynx, larynx, esophagus, pancreas, kidney, bladder

100 with newly diagnosed SCC of the oral cavity, oropharynx, larynx, or nasopharynx was used.

101 s including malignancies of the oral cavity, oropharynx, larynx, sinuses, and skull base.

102 as performed in which the anterior nares and oropharynx of 137 livestock veterinarians were sampled f

103 persist in human saliva and to colonize the oropharynx of mice, and seldom caused human pharyngitis.

104 vagus nerve that innervate taste buds of the oropharynx of the goldfish, Carassius auratus, project t

105 er intranasal inoculation, GAS colonized the oropharynx of wild-type mice but failed to colonize tran

106 and phenotypic changes in P. aeruginosa from oropharynx (OP) and bronchoalveolar lavage fluid (BALF)

107 resectable stage III/IVA and IVB larynx and oropharynx (OP) cancer patients.

108 includes tumours of the oral cavity (OSCC), oropharynx (OPSCC) and nasopharynx (NPC).

109 cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC) in a large multicenter cohort, using

110 t the initial visit for cancer affecting the oropharynx or gastrointestinal tract or advanced cancer,

111 eillance cultures were taken from the nares, oropharynx or trachea, and any open wound routinely on a

112 or IV squamous carcinoma of the oral cavity, oropharynx, or hypopharynx were eligible.

113 ncident HNSCC, which includes cancers of the oropharynx, oral cavity, and larynx.

114 een mouth position and dynamic motion in the oropharynx (P =.006) and in the nasopharynx (P <.006) bu

115 othesized that anatomic abnormalities of the oropharynx, particularly narrowing of the airway by the

116 age III or IV squamous-cell carcinoma of the oropharynx, positive for HPV by p16 testing, and with Zu

117 seven previously untreated patients (41 with oropharynx primaries; 33 men, 14 women; median age, 53 y

118 an Karnofsky status, 90%; range, 70% to 90%; oropharynx primary tumor, 59% of patients; T4, 36%; N2/3

119 patients (66 with stage IV disease, 37 with oropharynx primary tumors, and 67 with performance statu

120 viding general epithelial innervation to the oropharynx project to non-gustatory hindbrain regions, i

121 tidis as they enter the bloodstream from the oropharynx protect against disseminated disease.

122 group A Streptococcus (GAS) infection of the oropharynx provokes a distinct host transcriptome respon

123 n SPM site for patients with oral cavity and oropharynx SCC was HN; for patients with laryngeal and h

124 age III to IV squamous cell carcinoma of the oropharynx (SCCOP) were treated with one cycle of cispla

125 and prognosis of squamous cell carcinoma of oropharynx (SCCOP).

126 HPV16-associated squamous cell carcinoma of oropharynx (SCCOP).

127 by twice weekly monitoring of cultures from oropharynx, stools, urine, skin, and/or respiratory trac

128 Sensory inputs from the oropharynx terminate in both the trigeminal brainstem co

129 ominantly exists as a colonizer of the human oropharynx that occasionally breaches epithelial barrier

130 tarch and glycogen are abundant in the human oropharynx, the main site of group A Streptococcus (GAS)

131 group A Streptococcus (GAS) to colonize the oropharynx, the major site of GAS infection in humans.

132 from the atrophied part of the tongue in the oropharynx to the edematous part outside the mouth.

133 Daily surveillance cultures of the nares, oropharynx, trachea, and stomach demonstrated that trach

134 ultures from body sites (rectum, groin, arm, oropharynx, trachea, and stomach) and from environmental

135 Patients with p16-positive oropharynx tumors showed markedly improved survival outc

136 tcome relative to patients with p16-negative oropharynx tumors.

137 s-sectional area was measured in the rostral oropharynx, velopharynx, and caudal oropharynx, with and

138 sterior and lateral diameters in the rostral oropharynx, velopharynx, and caudal oropharynx.

139 cacy of topical chlorhexidine applied to the oropharynx vs. placebo or standard care for prevention o

140 Site of airway closure above or below the oropharynx was determined by measuring the respective pr

141 The oropharynx was most commonly collapsed in 98 (66%) of th

142 Clearance in the oropharynx was significantly decreased in those patients

143 on about how GAS survives in and infects the oropharynx, we analyzed the transcriptome of a serotype

144 phagus, scant attention has been paid to the oropharynx, which is often equally affected.

145 ame cage became chronically colonized in the oropharynx with environmental P. aeruginosa when the bac

146 al hypoglossus stimulation and in the caudal oropharynx with independent and combined hypoglossal bra

147 We show CWD uptake occurs in the oropharynx with initial prion replication in the drainin

148 and stimulation were present in the rostral oropharynx with medial hypoglossus stimulation and in th

149 repaired isogenic strain colonized the mouse oropharynx with significantly greater bacterial burden a

150 rostral oropharynx, velopharynx, and caudal oropharynx, with and without nerve stimulation.

151 lerated without adverse reactions beyond the oropharynx, with no severe symptoms or uses of epinephri

152 improved visualization of the tumors of the oropharynx, without disfiguring incisions.